Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Monsanto Company (MON) And E I Du Pont De Nemours And Co (DD) Have Spent $8 Million This Week To Defeat GMO Labeling Law In Washington

This November voters in Washington will be deciding on labeling of genetically modified foods via Washington Initiative 522, and thus far the biotech/agribusiness industry is coming out swinging spending millions in less than a week to defeat the measure. Monsanto Company (NYSE:MON) has spent $4.5 million this week while E I Du Pont De Nemours And Co (NYSE:DD) has shoveled another $3.25 million into the battle. Combine this with $500,000 spent by Bayer a few weeks ago and you can see that the industry isn’t taking this lightly.

Monsanto Company (NYSE:MON)

One can expect the spending to increase dramatically as Monsanto Company (NYSE:MON) and its cohorts have fought hard to water down a GMO labeling bill in Connecticut and recently spent over $50 million to defeat GMO labeling in California. What makes the full on media blitz and dollars spent to stop these laws curious is that polls show the vast majority of Americans are in fact in favor of required labeling for genetically modified foods. A recent poll from the New York Times returned results showing 93% of respondents wanted GMOs identified. The recent sustained selling in Monsanto Company (NYSE:MON)’s stock has even led many to believe hedge funds are growing weary of the increasing battles against modified crops.

Floating Path explores economic and cultural phenomena, and hopes to educate, inspire and provoke. Discover their wide range of daily content here.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!